A Single-center, Randomized, Double-blind, Placebo-controlled, Multiple-dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Samidorphan in Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 13 Oct 2015
At a glance
- Drugs Samidorphan (Primary)
- Indications Alcoholism; CNS disorders; Drug abuse
- Focus Adverse reactions; Pharmacokinetics
- 13 Oct 2015 New trial record